Prestige Consumer Healthcare
PBH
#3933
Rank
NZ$5.31 B
Marketcap
NZ$110.56
Share price
-0.25%
Change (1 day)
-26.30%
Change (1 year)

Market capitalization of Prestige Consumer Healthcare (PBH)

Market cap: NZ$5.31 Billion

As of February 2026 Prestige Consumer Healthcare has a market cap of NZ$5.31 Billion. This makes Prestige Consumer Healthcare the world's 3933th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Prestige Consumer Healthcare from 2005 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.31 B-0.43%
2025NZ$5.33 B-22.31%
2024NZ$6.87 B43.08%
2023NZ$4.80 B-1.63%
2022NZ$4.88 B9.76%
2021NZ$4.44 B83.74%
2020NZ$2.42 B-19.88%
2019NZ$3.02 B26.73%
2018NZ$2.38 B-28.1%
2017NZ$3.31 B-16.7%
2016NZ$3.98 B0.34%
2015NZ$3.96 B71.36%
2014NZ$2.31 B2.67%
2013NZ$2.25 B81.54%
2012NZ$1.24 B70.58%
2011NZ$0.72 B-6.12%
2010NZ$0.77 B43.28%
2009NZ$0.54 B-40.51%
2008NZ$0.91 B86.38%
2007NZ$0.48 B-47.16%
2006NZ$0.92 B0.95%
2005NZ$0.91 B

End of Day market cap according to different sources

On Feb 14th, 2026 the market cap of Prestige Consumer Healthcare was reported to be:

NZ$5.23 Billion
by Nasdaq info icon info icon
NZ$5.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$970.90 B 18,163.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$619.14 B 11,546.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$521.88 B 9,717.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$259.57 B 4,782.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$324.62 B 6,006.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$25.42 B 378.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$165.27 B 3,008.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$195.74 B 3,582.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ$60.84 M-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.67 B-49.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel